KANUMA is indicated for the treatment of patients with a diagnosis of LAL-D, and is now approved by the FDA. Once your doctor has determined that KANUMA is right for you, sign up for OneSource™, a personalized patient support program from Alexion Pharmaceuticals.
How to Apply
Please either download the application below (if available) or go to the program website for more information on how to apply. Once you fill out your application, send it to the address on the application. Remember not to send program applications to PPA.